Antimicrobial resistance in Haemophilus influenzae

References

1. Barany F., Kahn M. E. 1985; Comparison of transformation mechanisms of Haemophilus parainfluenzae and Haemophilus influenzae. Journal of Bacteriology 161:72–79
   [Google Scholar]
2. Bell S. M., Plowman D. 1980; Mechanisms of ampicillin resistance in Haemophilus influenzae from respiratory tract. Lancet 1:279–280
   [Google Scholar]
3. Burns J. L., Mendelman P. M., Levy J., Stull T. L., Smith A. L. 1985; A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 27:46–54
   [Google Scholar]
4. Campos J., Tornel S., Gairi J. M., Fabregues I. 1986; Multiply resistant Haemophilus influenzae type b causing meningitis: comparative clinical and laboratory study. Journal of Paediatrics 108:897–902
   [Google Scholar]
5. Campos J., Garcia-Tornel S. 1987; Comparative susceptibilities of ampicillin and chloramphenicol resistant Haemophilus influenzae to fifteen antibiotics. Journal of Antimicrobial Chemotherapy 19:297–301
   [Google Scholar]
6. Campos J., Tornel S., Musser J. M., Selander R. K., Smith A. L. 1987; Molecular epidemiology of multiply resistant Haemophilus influenzae type b in day care centers. Journal of Infectious Diseases 156:483–489
   [Google Scholar]
7. Dabemat H., Delmas C., Lareng M. B. 1986; Prevalence de la resistance aux antibiotiques des Haemophilus influenzae isoles en France: un an d’activite du reseau de surveillance des infections a H, influenzae. Pathologie et Biologic 34:372–378
   [Google Scholar]
8. Doern G. V., Jorgensen J. H., Thornsberry C., Preston D. A. 1986; Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collective study. Diagnostic Microbiology and Infectious Disease 4:95–107
   [Google Scholar]
9. Doern G. V. 1988; National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 32:180–185
   [Google Scholar]
10. Eskola J. 1987; Secondary cases of invasive disease caused by spread of Haemophilus influenzae type b. Journal of Infection 14:233–236
    [Google Scholar]
11. Fernandes P. B. 1987; Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicaemia model. Antimicrobial Agents and Chemotherapy 31:1243–1250
    [Google Scholar]
12. de Graaff J., Elwell L. P., Falkow S. 1976; Molecular nature of two beta-lactamase-specifying plasmids isolated from Haemophilus influenzae type b. Journal of Bacteriology 126:439–446
    [Google Scholar]
13. Granoff D. M., Gilsdorf J., Gessert C., Basden M. 1979; Haemophilus influenzae type b disease in a day care center: eradication of carrier state by rifampicin. Paediatrics 63:397–401
    [Google Scholar]
14. Granoff D. M., Munson R. S. 1986; Prospects for prevention of Haemophilus influenzae type b disease by immunization. Journal of Infectious Diseases 153:448–461
    [Google Scholar]
15. de Groot R., Campos J., Moseley S. L., Smith A. L. 1988; Molecular cloning and mechanism of trimethoprim resistance in Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 30:477–484
    [Google Scholar]
16. Gunn B. A., Woodall J. B., Jones J. F., Thornsberry C. 1974; Ampicillin-resistant Haemophilus influenzae. Lancet 1:845
    [Google Scholar]
17. Howard A. J., Hince C. J., Williams J. D. 1978; Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae. British Medical Journal 1:1657–1660
    [Google Scholar]
18. Jahn G., Laufs R., Kaulfers P. M., Kolenda H. 1979; Molecular nature of two Haemophilus influenzae R factors containing resistances and the multiple integration of drug resistance transposons. Journal of Bacteriology 138:584–597
    [Google Scholar]
19. Kirven L. A., Thornsberry C. 1978; Minimum bactericidal concentration of sulphamethoxazole-trimethoprim for Haemophilus influenzae: correlation with prophylaxis.. Antimicrobial Agents and Chemotherapy 14:731–736
    [Google Scholar]
20. van Klingeren B., van Embden J. D. A., Dessens-Kroon M. 1977; Plasmid-mediated chloramphenicol resistance in Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 11:383–387
    [Google Scholar]
21. Levy S. B., Hoi A., Marshall B. 1984; Transposon Tn10-like tetracycline resistance determinants in Haemophilus parainfluenzae. Journal of Bacteriology 160:87–94
    [Google Scholar]
22. Loeb M. R., Smith D. H. 1980; Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infection and Immunity 30:709–717
    [Google Scholar]
23. Machka K. 1988; Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study. European Journal of Clinical Microbiology 7:14–24
    [Google Scholar]
24. Makover D. S., Wright R., Telep E. 1981; Penicillin-binding proteins in Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 19:584–588
    [Google Scholar]
25. Markowitz S. M. 1980; Isolation of an ampicillin–resistant, non-beta-lactamase producing strain of Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 17:80–83
    [Google Scholar]
26. Marshall B., Roberts M., Smith A., Levy S. B. 1984; Homogeneity of transferable tetracycline-resistance determinants in Haemophilus species. Journal of Infectious Diseases 149:1028–1029
    [Google Scholar]
27. Medeiros A. A., Brien T. F. 1975; Ampicillin-resistant Haemophilus influenzae type b possessing a TEM-type β-lactamase but little permeability barrier to ampicillin. Lancet 1:716–719
    [Google Scholar]
28. Medeiros A. A., Levesque R., Jacoby G. A. 1986; An animal source for the ROB-1 β-lactamase of Haemophilus influenzae type b. Antimicrobial Agents and Chemotherapy 29:212–215
    [Google Scholar]
29. Mendelman P. M., Roberts M. C., Smith A. L. 1982; Mutation frequency of Haemophilus influenzae to rifampicin resistance. Antimicrobial Agents and Chemotherapy 22:531–533
    [Google Scholar]
30. Mendelman P. M., Doroshow C. A., Gandy S. L., Syriopoulou V., Weigen C. P., Smith A. L. 1984a; Plasmid-mediated resistance in multiply resistant Haemophilus influenzae type b causing meningitis: molecular characterization of one strain and review of the literature. Journal of Infectious Diseases 150:30–39
    [Google Scholar]
31. Mendelman P. M., Chaffin D. O., Stull T. L., Rubens C. E., Mack K. D., Smith A. L. 1984b; Characterization of non-β-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 26:235–244
    [Google Scholar]
32. Mendelman P. M., Syriopoulou V. P., Gandy S. L., Ward J. I., Smith A. L. 1985; Molecular epidemiology of plasmid–mediated ampicillin-resistance in Haemophilus influenzae type b isolates from Alaska. Journal of Infectious Diseases 151:1061–1072
    [Google Scholar]
33. Mendelman P. M., Chaffin D. O., Musser J. M., de Groot R., Serfass D. A., Selander R. K. 1987; Genetic and phenotypic diversity among ampicillin-resistant, non-β-lactamase-producing, nontypeable Haemophilus influenzae isolates. Infection and Immunity 55:2585–2589
    [Google Scholar]
34. Murphey-Corb M., Willard M., Daum R. S. 1984; Integration of plasmid DNA coding for beta-lactamase production in the Haemophilus influenzae chromosome. Journal of Bacteriology 160:815–817
    [Google Scholar]
35. Nicolle L. E. 1982; Eme^rgence of rifampin-resistant Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 21:498–500
    [Google Scholar]
36. Offit P. A., Campos J. M., Plotkin S. A. 1982; Ampicillin-resistant, beta-lactamase-negative Haemophilus influenzae type b. Paediatrics 69:230–232
    [Google Scholar]
37. Parr T. R., Bryan L. E. 1984; Mechanism of resistance of an ampicillin-resistant, β-lactamase-negative clinical isolate of Haemophilus influenzae type b to β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 25:747–753
    [Google Scholar]
38. Powell M., Williams J. D. 1987a; In vitro susceptibility of Haemophilus influenzae to cefixime. Antimicrobial Agents and Chemotherapy 31:1841–1842
    [Google Scholar]
39. Powell M., Williams J. D. 1987b; In vitro activities of aztreonam, imipenem and amoxycillin-clavulanate against ampicillin-resistant Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 31:1871–1873
    [Google Scholar]
40. Powell M., Carouzou C., Voutsinas D., Seymour A., Williams J. D. 1987; Resistance of clinical isolates of Haemophilus influenzae in United Kingdom 1986. British Medical Journal 295:176–179
    [Google Scholar]
41. Powell M., Livermore D. M. 1988; Mechanisms of chloramphenicol resistance in Haemophilus influenzae in the United Kingdom. Journal of Medical Microbiology 27:89–93
    [Google Scholar]
42. Powell M., Williams J. D. 1988; Detection of ampicillin-resistant Haemophilus influenzae in United Kingdom laboratories. Journal of Clinical Pathology 41:716–719
    [Google Scholar]
43. Raoof S., Wollschlager C., Khan F. 1986; Treatment of respiratory tract infections with ciprofloxacin. Journal of Antimicrobial Chemotherapy 18: Suppl D139–145
    [Google Scholar]
44. Reid A. J., Simpson I. N., Harper P. B., Amyes S. G. B. 1987; Ampicillin resistance in Haemophilus influenzae: identification of resistance mechanisms. Journal of Antimicrobial Chemotherapy 20:645–656
    [Google Scholar]
45. Roberts M. C., Smith A. L. 1980; Molecular characterization of ‘plasmid-free’ antibiotic resistant Haemophilus influenzae. Journal of Bacteriology 144:476–479
    [Google Scholar]
46. Roberts M. C., Swenson C. D., Owens L. M., Smith A. L. 1980; Characterization of chloramphenicol-resistant Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 18:610–615
    [Google Scholar]
47. Roberts M., Comey A., Shaw W. V. 1982; Molecular characterization of three chloramphenicol acetyltransferases isolated from Haemophilus influenzae. Journal of Bacteriology 151:737–741
    [Google Scholar]
48. Rubin L. G., Medeiros A. A., Yolken R. H., Moxon E. R. 1981; Ampicillin treatment failure of apparently β-lactamase-negative Haemophilus influenzae type b meningitis due to novel β-lactamase. Lancet 2:1008–1010
    [Google Scholar]
49. Serfass D. A., Mendelman P. M., Chaffin D. O., Needham C. A. 1986; Ampicillin resistance and penicillin-binding proteins of Haemophilus influenzae. Journal of General Microbiology 132:2855–2861
    [Google Scholar]
50. Steen R., Skold O. 1985; Plasmid-bome or chromosomally-mediated resistance by Tn7 is the most common response to ubiquitous use of trimethoprim. Antimicrobial Agents and Chemotherapy 27:933–937
    [Google Scholar]
51. Stuy J. H. 1980; Chromosomally integrated conjugative plasmids are common in antibiotic resistant Haemophilus influenzae. Journal of Bacteriology 142:925–930
    [Google Scholar]
52. Vachon V., Lyew D. J., Coulton J. W. 1985; Transmembrane permeability channels across the outer membrane of Haemophilus influenzae type b. Journal of Bacteriology 162:918–924
    [Google Scholar]
53. Yogev R., Moxon E. R. 1982; Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulphamethoxazole. Journal of Clinical Investigation 69:658–665
    [Google Scholar]